KLRK1 and myalgic encephalomeyelitis/chronic fatigue syndrome: NK cell cytotoxic activity can be regulated to by NKG2D, which is an activating receptor that has previously been significantly elevated in International Consensus Criteria for CFS/ME-defined CFS/ME patients when compared to CFS/ME patients defined using the 1994 Fukuda definition [5].